Rpl31 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RPL31 (Ribosomal Protein L31) is a component of the 60S ribosomal subunit and plays essential roles in protein synthesis. As part of the large ribosomal subunit, RPL31 contributes to the structural integrity of the ribosome and participates in various aspects of translational control. Beyond its canonical role in translation, RPL31 has been implicated in cellular processes that may be relevant to neurodegenerative diseases.
RPL31 is a 60S ribosomal protein encoded by the RPL31 gene.
- Molecular Weight: Approximately 14.5 kDa
- Amino Acids: 125 amino acids
- Isoforms: Multiple isoforms identified
- Subcellular Localization: Cytoplasmic, associated with the 60S ribosomal subunit
- Domain Structure: Contains ribosomal protein L31 domain
As a component of the 60S ribosomal subunit, RPL31 contributes to:
- Peptidyl Transferase Activity: Participates in peptide bond formation
- Ribosome Structure: Maintains structural integrity of the large subunit
- Translation Elongation: Functions during the elongation phase of translation
- Cell Cycle Regulation: RPL31 may influence cell cycle progression
- Apoptosis: Some studies suggest roles in apoptotic pathways
¶ Translation and Neurodegeneration
Dysregulated translation is a feature of many neurodegenerative diseases. RPL31 may contribute through:
- Protein Synthesis Deficits: Impaired ribosomal function reduces protein synthesis capacity
- Synaptic Dysfunction: Local translation at synapses is crucial for neuronal function
- Stress Response: Ribosomal proteins can be recruited to stress granules
In Alzheimer's disease:
- Impaired translation may contribute to synaptic protein deficits
- Ribosomal dysfunction may affect tau and amyloid processing
In Parkinson's disease:
- Mitochondrial protein synthesis may be affected
- Alpha-synuclein translation may be dysregulated
The study of Rpl31 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Structure of the human 60S ribosome (2020)
- Ribosomal proteins in neurodegeneration (2022)
- Translation in Alzheimer's disease (2021)
- Ribosome quality control (2023)
- Synaptic translation mechanisms (2022)
- mTOR and translation (2021)